Sheila Frame: What Excites Sandoz About Biosimilars

Transcript

So at Sandoz we're just so thrilled with the experience. We have 20 years' worth of experience in biologics, 340 million patient days of exposures to biosimilars in 86 countries. We are so excited for the value that we can bring to Americans. They so deserve getting access to these important products, both from us and from our industry colleagues, in order to free up capacity for the new innovations that are coming, but also, and importantly, to get the benefit of the savings and increased access that they'll have.